highly significantp < 0.001
Although a significant increase in the SBP ( p < 0.05) was also observed when CEL was administered with FA (Group-VI) at the end of 3rd and 4th weeks of treatment compared to baseline, there was a significant decrease at the end of the 3rd week ( p < 0.05) and a highly significant decrease in the SBP at the end of the 4th week ( p < 0.001) when compared to CEL treatment alone.